Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -1.21 % |
3 Month Return | + 6.65 % |
1 Year Return | + 133.22 % |
Market Stats | |
Previous Close | ₹861.85 |
Open | ₹850.15 |
Volume | 7,581.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹897.80Cr |
P/E Ratio | 31.16 |
PEG Ratio | 1.84 |
Market Cap | ₹897.80 Cr |
P/B Ratio | 1.89 |
EPS | 22.76 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 13.74 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹897.80 Cr | 654.64% | 0.65 | ₹23 Cr | ₹307 Cr | |
NA | ₹435.76 Cr | 272.24% | 0.54 | ₹28 Cr | ₹601 Cr | |
NA | ₹15.41 Cr | 278.33% | 0.50 | NA | NA | |
BUY | ₹23,100.09 Cr | 3.59% | 0.52 | NA | NA | |
NA | ₹706.49 Cr | -0.07% | 0.57 | ₹9 Cr | ₹179 Cr |
Organisation | Kwality Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Kwality Pharmaceuticals Ltd
ED Raids Linked to Kwality Ltd Bank Fraud - 27 Nov, 2024
Kwality Pharma Gains Approval for PEGylated-Asparaginase - 26 Nov, 2024
Kwality Pharma Expands into European Market - 06 Nov, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, Kwality Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Revenue Rich
Revenue is up for the last 2 quarters, 80.36 Cr → 90.26 Cr (in ₹), with an average increase of 11.0% per quarter
Profit Spike
Netprofit is up for the last 3 quarters, 4.36 Cr → 8.47 Cr (in ₹), with an average increase of 24.6% per quarter
Price Rise
In the last 6 months, Kwality Pharma stock has moved up by 57.7%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 127.5%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 54.83% of holdings in Sep 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 45.17% to 45.15% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 54.83% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 45.15% | ||
Others | 0.02% | 0.00 |
Kwality Pharmaceuticals Ltd in the last 5 years
Lowest (2.58x)
June 29, 2022
Today (31.16x)
December 19, 2024
Industry (56.23x)
December 19, 2024
Highest (46.50x)
February 21, 2024
Kwality Pharmaceuticals Ltd’s net profit jumped 35.74% since last year same period to ₹8.47Cr in the Q2 2024-2025. On a quarterly growth basis, Kwality Pharmaceuticals Ltd has generated 1.32% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2016, Kwality Pharmaceuticals Ltd has declared dividend of ₹0.60 - translating a dividend yield of 0.07%.
Read More about DividendsBearish
Neutral
Bullish
Kwality Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
Kwality Pharmaceuticals Ltd (539997) share price today is ₹867
Kwality Pharmaceuticals Ltd is not listed on NSE
Kwality Pharmaceuticals Ltd is listed on BSE
PE Ratio of Kwality Pharmaceuticals Ltd is 31.16
PE ratio = Kwality Pharmaceuticals Ltd Market price per share / Kwality Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Kwality Pharmaceuticals Ltd(539997) is 7,581.00.
Today’s market capitalisation of Kwality Pharmaceuticals Ltd(539997) is ₹897.8Cr.
Kwality Pharmaceuticals Ltd(539997 | Price |
---|---|
52 Week High | ₹961.15 |
52 Week Low | ₹362.95 |
Kwality Pharmaceuticals Ltd(539997) share price is ₹867. It is down -9.80% from its 52 Week High price of ₹961.15
Kwality Pharmaceuticals Ltd(539997) share price is ₹867. It is up 138.88% from its 52 Week Low price of ₹362.95
Kwality Pharmaceuticals Ltd(539997 | Returns |
---|---|
1 Day Returns | 5.15% |
1 Month Returns | -1.21% |
3 Month Returns | 6.65% |
1 Year Returns | 133.22% |